ApoE-ε4 genotype became an important risk factor in recent years because having an ApoE-ε4 allele showed an increased risk; about 60% of the patients diagnosed with AD were ApoE-ε4 carriers [5,9]. This evidence concerns the gene APOE and Alzheimer disease.